UK-US Agree Zero-Tariff Pharmaceuticals Deal
The UK and US have finalised a landmark trade agreement to eliminate tariffs on pharmaceutical products. Discover how this deal aims to lower drug costs and boost medical innovation.
Category : Search result: zerotariff pharmaceuticals
UK-US set for zero-tariff pharma deal amid NHS price row
The UK is poised to strike a deal with the US removing tariffs on pharmaceuticals, following warnings of investment cuts. The agreement hinges on the NHS paying more for American medicines. Read the full details.
Trump's Secret Stance on Weight Loss Drugs Exposed
Explosive revelations emerge about Donald Trump's private stance on revolutionary weight loss drugs while new research highlights their massive economic potential.
FDA warns of toxic cough syrups from China
US health authorities sound alarm after toxic chemical discovery in Chinese-manufactured cough syrups distributed across multiple states, prompting urgent product recalls.
Dr Oz Faces Backlash Over Trump Drug Pricing Comments
Former TV doctor and Senate candidate Mehmet Oz under fire after resurfaced video reveals his support for Trump administration's drug pricing policies that critics say favoured pharmaceutical giants.
Antidepressant linked to heart risk and weight gain
A comprehensive safety review of a widely prescribed antidepressant has uncovered significant cardiovascular concerns and substantial weight gain among users, raising urgent questions about prescription practices.
Ibuprofen's Cancer Prevention Potential Revealed
Groundbreaking research reveals ibuprofen's potential cancer-prevention properties, challenging everything we thought we knew about this everyday medication.
Trump drug price threat could hit NHS patients
Former President Donald Trump's proposal to make other nations pay 'full price' for US pharmaceuticals could dramatically increase drug costs for the NHS, potentially forcing British taxpayers to foot a multi-billion pound bill.
NHS may pay 25% more for medicines in new deal
Exclusive: The NHS could pay up to 25% more for vital medicines under a proposed voluntary scheme aimed at resolving long-standing tensions with pharmaceutical companies and preventing potential supply disruptions.
Common UK painkiller linked to blood cancer risk
Groundbreaking research reveals a widely prescribed pain medication used by millions in Britain could increase the risk of developing blood cancers. Experts urge caution.
Trump's Drug Pricing Overhaul Targets Pfizer
Exclusive investigation reveals Donald Trump's radical plans to overhaul pharmaceutical pricing, with potential seismic implications for Britain's National Health Service and prescription charges.
FDA warns against unapproved 'autism pill' treatment
Medical authorities sound alarm about unapproved use of leucovorin for autism treatment after prominent doctor's claims about 'miracle pill' results. Exclusive investigation reveals growing concerns among healthcare professionals.
Tylenol Autism Lawsuits: US Crisis Sparks UK Health Warning
Major US lawsuits linking Tylenol (paracetamol) to autism in children raise serious questions for UK parents and health officials. Learn about the scientific claims and legal battles.
Pfizer Revives Weight-Loss Pill to Challenge Obesity Drug Leaders
Pfizer announces a surprising turnaround in its weight-loss strategy, advancing two new daily pills in a heated battle for the lucrative obesity drug market dominated by injectables.
'Youth Pill' Targets Brain Aging in Dementia Breakthrough
A groundbreaking pill from Retro Biosciences promises to reverse brain aging and combat dementia. Early human trials show potential to revolutionise Alzheimer's treatment. Discover the science behind this medical marvel.
UK signs deal for Merck's groundbreaking Covid-19 pill
The UK government has secured 250,000 courses of Merck's molnupiravir, an innovative antiviral pill shown to halve hospitalisations in a major scientific breakthrough.
Eli Lilly shuts London research centre in major UK science blow
In a significant setback for British research, pharmaceutical titan Eli Lilly is closing its London research and development hub, putting over 100 jobs at risk and raising concerns about the UK's post-Brexit scientific competitiveness.
Pharma Giant Cuts 9,000 Jobs in Major Restructure
A major pharmaceutical multinational has announced a drastic cost-cutting plan, putting 9,000 roles at risk globally. The move signals deepening turmoil within the industry, raising concerns for the UK's strategic life sciences sector.
Novo Nordisk's £90m UK Expansion for Ozempic Production
Danish pharmaceutical giant Novo Nordisk announces major £90 million expansion at its Gatwick facility to meet soaring global demand for its blockbuster diabetes and weight-loss drugs, Ozempic and Wegovy, creating new high-skilled jobs.
Novo Nordisk cuts 9,000 jobs amid Ozempic competition
Danish pharmaceutical giant Novo Nordisk announces major restructuring, cutting 9,000 jobs globally. The move comes as competition intensifies in the lucrative weight-loss and diabetes drug market, challenging its blockbuster medications Ozempic and Wegov
Gates Foundation invests $40m in African vaccine production
The Bill & Melinda Gates Foundation announces a major $40m investment in Nigerian and Senegalese vaccine production, aiming to boost Africa's pharmaceutical sovereignty and pandemic resilience.
From Vet to Vet: The Canine Diabetes Drug Changing Human Lives
The incredible story of exenatide, a diabetes medication developed for dogs, that is now revolutionising human weight loss treatments and reshaping our understanding of obesity.
Streeting Confronts Pharma Giants Over NHS Drug Pricing
Health Secretary Wes Streeting confronts major pharmaceutical firms, demanding transparency and fair pricing in the NHS's voluntary rebate scheme, which recouped £1.4bn last year.
Eli Lilly reduces Mounjaro price in UK after Trump criticism
Pharmaceutical giant Eli Lilly reduces the UK price of its weight-loss drug Mounjaro following backlash, including criticism from former US President Donald Trump.
RFK Jr cancels mRNA vaccine development
Robert F. Kennedy Jr cancels plans to develop mRNA vaccines, citing safety concerns and ethical issues. Read the latest updates on this controversial decision.
Male contraceptive pill trial shows promise despite side effects
A new male contraceptive pill shows high efficacy in trials, though some participants reported side effects. Could this revolutionise birth control?
EU probes Swiss pharma over Trump-era deals
European Union investigates Swiss pharmaceutical firms Roche and Novartis for potential antitrust violations in deals connected to Donald Trump's administration.
European pharma firms blast Trump's medicine tariffs
Leading European pharmaceutical firms have condemned the Trump administration's new tariffs on medicines, warning they will drive up costs and limit access to vital treatments.
UK pharma may dodge Trump's steel tariffs
Former US President Donald Trump's proposed tariffs on UK steel exports may be offset by concessions for the British pharmaceutical industry, according to insider reports.
NHS England secures cystic fibrosis drug deal
NHS England secures deal to expand access to Orkambi for cystic fibrosis patients after prolonged negotiations with Vertex Pharmaceuticals.
Page 1 of 1